Michael K. Handley
Chief Executive Officer, Director · Valion Bio, Inc.
Individual
- 2025
- May 20, 2026
- 3
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Michael K. Handley files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Christina Rizopoulos Valauri - $18K in VBIO purchases and sales in the last 12 months
- Sheryle Bolton - $10K in VBIO purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Michael K. Handley?
Michael K. Handley is a corporate insider, tracked as Chief Executive Officer, Director of Valion Bio, Inc. (VBIO). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Michael K. Handley last file a Form 4?
The most recent primary Form 4 on record is dated 20 May 2026, one of 3 filings going back to 2025.
